CSPI comments to FDA re: "Guidance for Industry" CSPI's comments on FDA draft “Guidance for Industry: Drugs, Biologics, and Medical Devices Derived From Bioengineered Plants for Use in Humans and Animals." View resource Tags Food and Drug Administration Topics New Food Technologies Government Accountability
CSPI's comments on FDA draft “Guidance for Industry: Drugs, Biologics, and Medical Devices Derived From Bioengineered Plants for Use in Humans and Animals." View resource Tags Food and Drug Administration Topics New Food Technologies Government Accountability
CSPI's comments on FDA draft “Guidance for Industry: Drugs, Biologics, and Medical Devices Derived From Bioengineered Plants for Use in Humans and Animals."